Increased Thioredoxin-1 Expression Promotes Cancer Progression and Predicts Poor Prognosis in Patients with Gastric Cancer
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Increased Thioredoxin-1 Expression Promotes Cancer Progression and Predicts Poor Prognosis in Patients with Gastric Cancer
Authors
Keywords
-
Journal
Oxidative Medicine and Cellular Longevity
Volume 2019, Issue -, Pages 1-15
Publisher
Hindawi Limited
Online
2019-02-19
DOI
10.1155/2019/9291683
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Interplay between Trx-1 and S100P promotes colorectal cancer cell epithelial-mesenchymal transition by up-regulating S100A4 through AKT activation
- (2018) Zhigui Zuo et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Redox signaling in the gastrointestinal tract
- (2017) Salvador Pérez et al. FREE RADICAL BIOLOGY AND MEDICINE
- miR-600 inhibits cell proliferation, migration and invasion by targeting p53 in mutant p53-expressing human colorectal cancer cell lines
- (2017) Peili Zhang et al. Oncology Letters
- Expression of Thioredoxins and Glutaredoxins in Human Hepatocellular Carcinoma: Correlation to Cell Proliferation, Tumor Size and Metabolic Syndrome
- (2017) A. Mollbrink et al. INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY
- Gastric cancer
- (2016) Eric Van Cutsem et al. LANCET
- The overexpression and nuclear translocation of Trx-1 during hypoxia confers on HepG2 cells resistance to DDP, and GL-V9 reverses the resistance by suppressing the Trx-1/Ref-1 axis
- (2015) Li Zhao et al. FREE RADICAL BIOLOGY AND MEDICINE
- Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
- (2014) Jacques Ferlay et al. INTERNATIONAL JOURNAL OF CANCER
- Thioredoxin-1 inhibitor, 1-methylpropyl 2-imidazolyl disulfide, inhibits the growth, migration and invasion of colorectal cancer cell lines
- (2014) FULE WANG et al. ONCOLOGY REPORTS
- PX-12 induces apoptosis in Calu-6 cells in an oxidative stress-dependent manner
- (2014) Bo Ra You et al. TUMOR BIOLOGY
- Regulation of the human thioredoxin gene promoter and its key substrates: A study of functional and putative regulatory elements
- (2013) Hye-Jin Kim Hawkes et al. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
- The thioredoxin antioxidant system
- (2013) Jun Lu et al. FREE RADICAL BIOLOGY AND MEDICINE
- PX-12 inhibits the growth of A549 lung cancer cells via G2/M phase arrest and ROS-dependent apoptosis
- (2013) BO RA YOU et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Gastric cancer—molecular and clinical dimensions
- (2013) Roopma Wadhwa et al. Nature Reviews Clinical Oncology
- PX-12-induced HeLa cell death is associated with oxidative stress and GSH depletion
- (2013) HYE RIM SHIN et al. Oncology Letters
- Akt-p53-miR-365-cyclin D1/cdc25A axis contributes to gastric tumorigenesis induced by PTEN deficiency
- (2013) Shui-Long Guo et al. Nature Communications
- A phase IB trial of 24-hour intravenous PX-12, a thioredoxin-1 inhibitor, in patients with advanced gastrointestinal cancers
- (2012) A. F. Baker et al. INVESTIGATIONAL NEW DRUGS
- Thioredoxin from the Indianmeal Moth Plodia interpunctella: Cloning and Test of the Allergenic Potential in Mice
- (2012) Elisabeth Hoflehner et al. PLoS One
- Thioredoxin and thioredoxin-interacting protein as prognostic markers for gastric cancer recurrence
- (2012) Jae Yun Lim WORLD JOURNAL OF GASTROENTEROLOGY
- Estrogen Receptor-β and Fetoplacental Endothelial Prostanoid Biosynthesis: A Link to Clinically Demonstrated Fetal Growth Restriction
- (2011) Emily J. Su et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Comparative epidemiology of gastric cancer between Japan and China
- (2011) Yingsong Lin WORLD JOURNAL OF GASTROENTEROLOGY
- A randomized phase II study of PX-12, an inhibitor of thioredoxin in patients with advanced cancer of the pancreas following progression after a gemcitabine-containing combination
- (2010) Ramesh K. Ramanathan et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Anti-oxidative, anti-cancer and anti-inflammatory actions by thioredoxin 1 and thioredoxin-binding protein-2
- (2010) Rie Watanabe et al. PHARMACOLOGY & THERAPEUTICS
- Overexpression of peroxiredoxin I and thioredoxin1 in human breast carcinoma
- (2009) Mee-Kyung Cha et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Activated Akt as an indicator of prognosis in gastric cancer
- (2008) Caterina Cinti et al. VIRCHOWS ARCHIV
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started